ResMed (RMD) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7611521078

ResMed Inc., traded as NYSE:RMD, is a company focusing on developing, creating, distributing, and promoting medical devices and cloud-based software applications tailored for the healthcare sector. The company operates within two main segments: Sleep and Respiratory Care, along with Software as a Service. Providing a wide array of products and solutions for numerous respiratory disorders, ResMed offers advanced technologies for medical and consumer products, ventilation devices, diagnostic tools, mask systems suitable for both hospital and home use, headgear and various accessories, dental devices, and cloud-based software informatics aimed at managing patient outcomes and enhancing customer and business processes.

In addition to its core offerings, ResMed provides a range of innovative products such as AirView, a cloud-based system facilitating remote monitoring and adjustment of patients' device settings; myAir, a personalized therapy management app designed for patients dealing with sleep apnea, delivering support, educational resources, and troubleshooting tools to boost patient engagement and adherence. Moreover, the company offers solutions like U-Sleep, a compliance monitoring tool that helps home medical equipment (HME) providers streamline their sleep programs; connectivity modules, and Propeller portal, among others.

Furthermore, ResMed extends its services with out-of-hospital software solutions such as Brightree business management software catering to HME providers, pharmacies, home infusion services, orthotics, and prosthetics; MatrixCare care management solutions for senior living, skilled nursing, life plan communities, home health, home care, hospice organizations, and related accountable care organizations; HEALTHCAREfirst electronic health record software, billing and coding services, and analytics for home health and hospice agencies; as well as MEDIFOX DAN's software solutions.

With its headquarters in San Diego, California, ResMed Inc. was established in 1989. The company reaches out to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and a competent direct sales force. For more information, you can visit their website at

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ResMed (RMD) - Stock Price & Dividends

RMD Stock Overview

Market Cap in USD 27,963m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1995-06-02

RMD Stock Ratings

Fundamental 8.11
Dividend 6.33
Growth 5y 3.35
Rel. Performance vs Sector -2.93
Analysts 4.07
Fair Price Total Ret. 167.84
Fair Price DCF 176.08

RMD Dividends

Yield 12m 1.04%
Yield on Cost 5y 1.91%
Dividends CAGR 5y 3.90%
Payout Consistency 100.0%

RMD Growth Ratios

Growth 12m -14.15%
Growth Correlation 12m -34%
Growth Correlation 3m 62%
CAGR 5y 12.89%
CAGR / Mean Drawdown 0.80
Sharpe Ratio 12m -0.58
Alpha vs SP500 12m -42.18
Beta vs SP500 5y weekly 0.93
CAPM 7.79%
Average Daily Range 2m 2.40%
Regime Oscillator 44.72
Volatility GJR Garch 1y 27.01%
Price / SMA 50 1.56%
Price / SMA 200 1.72%
Current Volume 666.9k
Average Volume 20d 766.5k

External Links for RMD Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of RMD stocks?
As of February 28, 2024, the stock is trading at USD 180.99 with a total of 666,918 shares traded.
Over the past week, the price has changed by +0.18%, over one month by -4.58%, over three months by +18.93% and over the past year by -13.70%.
Why is RMD stock down?
Check with which Index or Commodity RMD has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return RMD Return S&P 500
1 Month -4.58% 4.00%
3 Months 18.93% 11.99%
12 Months -13.70% 29.39%
What is the forecast for RMD stock price target?
According to ValueRays Forecast Model, RMD ResMed will be worth about 186.3 in February 2025. The stock is currently trading at 180.99. This means that the stock has a potential upside of +2.93%.
Issuer Forecast Upside
Wallstreet Target Price 201.3 11.2%
Analysts Target Price 184 1.7%
ValueRay Target Price 186.3 2.9%